12 March 2018

Amedeo Smart

Independent Medical Education


Subscriber: th..@boehringer-ingelheim.com

HIV Infection

12 March 2018 | n=46

  1. .
    Reducing HIV infection in people who inject drugs is impossible without targeting recently-infected subjects: Erratum.
    AIDS 2018;32:685.

  2. .
    Immunodeficiency, AIDS-related pneumonia, and risk of lung cancer among HIV-infected individuals: Erratum.
    AIDS 2018;32:681.

  3. .
    Soluble CD163 predicts incident chronic lung, kidney and liver disease in HIV infection: Erratum.
    AIDS 2018;32:679.

  4. Ismail MF, Wong DK, Bogoch II.
    The role for hepatitis A vaccination in HIV pre-exposure prophylaxis.
    AIDS 2018;32:675-676.

  5. Poizot-Martin I, Laroche H, Cano CE, Nicolino-Brunet C, et al.
    Cancer risk in HIV-infected patients: elite controllers are also concerned.
    AIDS 2018;32:673-675.

  6. Oldenburg CE, Chanda MM, Ortblad KF, Mwale M, et al.
    Effect of HIV self-testing on the number of sexual partners among female sex workers in Zambia.
    AIDS 2018;32:645-652.

  7. Hennink M, Kaiser B, Marconi V.
    Pathways to Retention in HIV Care among US Veterans.
    AIDS Res Hum Retroviruses 2018.

  8. Kleinstein SE, Shea PR, Stamm LM, Sulkowski M, et al.
    Association of CYP2B6 Single-Nucleotide Polymorphisms Altering Efavirenz Metabolism With Hepatitis C Virus (HCV) Treatment Relapse Among Human Immunodeficiency Virus/HCV-Coinfected African Americans Receiving Ledipasvir/Sofosbuvir in the ION-4 Trial.
    Clin Infect Dis 2018.

  9. Mogalian E, Stamm LM, Osinusi A, Brainard DM, et al.
    Drug-Drug Interactions Studies between HCV Antivirals Sofosbuvir/Velpatasvir and Boosted and Unboosted HIV Antiretroviral Regimens in Healthy Volunteers.
    Clin Infect Dis 2018.

  10. Ousley J, Niyibizi AA, Wanjala S, Vandenbulcke A, et al.
    High Proportions of Patients With Advanced HIV Are Antiretroviral Therapy Experienced: Hospitalization Outcomes From 2 Sub-Saharan African Sites.
    Clin Infect Dis 2018;66:S126-S131.

  11. Carmona S, Bor J, Nattey C, Maughan-Brown B, et al.
    Persistent High Burden of Advanced HIV Disease Among Patients Seeking Care in South Africa's National HIV Program: Data From a Nationwide Laboratory Cohort.
    Clin Infect Dis 2018;66:S111-S117.

  12. Frigati L, Archary M, Rabie H, Penazzato M, et al.
    Priorities for Decreasing Morbidity and Mortality in Children With Advanced HIV Disease.
    Clin Infect Dis 2018;66:S147-S151.

  13. Ford N, Shubber Z, Jarvis JN, Chiller T, et al.
    CD4 Cell Count Threshold for Cryptococcal Antigen Screening of HIV-Infected Individuals: A Systematic Review and Meta-analysis.
    Clin Infect Dis 2018;66:S152-S159.

  14. Siika A, McCabe L, Bwakura-Dangarembizi M, Kityo C, et al.
    Late Presentation With HIV in Africa: Phenotypes, Risk, and Risk Stratification in the REALITY Trial.
    Clin Infect Dis 2018;66:S140-S146.

  15. Post FA, Szubert AJ, Prendergast AJ, Johnston V, et al.
    Causes and Timing of Mortality and Morbidity Among Late Presenters Starting Antiretroviral Therapy in the REALITY Trial.
    Clin Infect Dis 2018;66:S132-S139.

  16. Osler M, Hilderbrand K, Goemaere E, Ford N, et al.
    The Continuing Burden of Advanced HIV Disease Over 10 Years of Increasing Antiretroviral Therapy Coverage in South Africa.
    Clin Infect Dis 2018;66:S118-S125.

  17. Ford N, Meintjes G, Calmy A, Bygrave H, et al.
    Managing Advanced HIV Disease in a Public Health Approach.
    Clin Infect Dis 2018;66:S106-SS110.

  18. Calmy A, Ford N, Meintjes G.
    The Persistent Challenge of Advanced HIV Disease and AIDS in the Era of Antiretroviral Therapy.
    Clin Infect Dis 2018;66:S103-SS105.

  19. Sekaggya-Wiltshire C, von Braun A, Lamorde M, Ledergerber B, et al.
    Delayed Sputum Conversion in TB-HIV Co-Infected Patients with Low Isoniazid and Rifampicin Concentrations.
    Clin Infect Dis 2018.

  20. Mutoh Y, Nishijima T, Inaba Y, Tanaka N, et al.
    Incomplete Recovery of CD4 count, CD4 Percentage, and CD4/CD8 ratio in HIV-Infected Patients on Long-Term Antiretroviral Therapy with Suppressed Viremia.
    Clin Infect Dis 2018.

  21. Traeger MW, Schroeder SE, Wright EJ, Hellard ME, et al.
    Effects of Pre-exposure Prophylaxis for the Prevention of HIV Infection on Sexual Risk Behavior in Men Who Have Sex with Men: A Systematic Review and Meta-analysis.
    Clin Infect Dis 2018.

  22. Letendre S, Bharti A, Perez-Valero I, Hanson B, et al.
    Higher Anti-CMV IgG Concentrations are Associated with Worse Neurocognitive Performance During Suppressive Antiretroviral Therapy.
    Clin Infect Dis 2018.

  23. Rusie LK, Orengo C, Burrell D, Ramachandran A, et al.
    PrEP Initiation and Retention in care over five years, 2012-2017: Are quarterly visits too much?
    Clin Infect Dis 2018.

  24. Labhardt ND, Ringera I, Lejone TI, Klimkait T, et al.
    Effect of Offering Same-Day ART vs Usual Health Facility Referral During Home-Based HIV Testing on Linkage to Care and Viral Suppression Among Adults With HIV in Lesotho: The CASCADE Randomized Clinical Trial.
    JAMA 2018.

  25. Katz IT, Ehrenkranz P, El-Sadr W.
    The Global HIV Epidemic: What Will It Take to Get to the Finish Line?
    JAMA 2018.

  26. Wools-Kaloustian K, Marete I, Ayaya S, Sohn AH, et al.
    Time to First-Line ART Failure and Time to Second-Line ART Switch in the IeDEA Pediatric Cohort.
    J Acquir Immune Defic Syndr 2018.

  27. Pathela P, Jamison K, Braunstein SL, Schillinger JA, et al.
    Gaps along the HIV care continuum: findings among a population seeking sexual health care services in New York City.
    J Acquir Immune Defic Syndr 2018.

  28. Nalintya E, Meya DB, Lofgren S, Hullsiek KH, et al.
    A Prospective Evaluation of a multisite Cryptococcal Screening and Treatment program in HIV clinics in Uganda.
    J Acquir Immune Defic Syndr 2018.

  29. Spittal PM, Malamba SS, Ogwang MD, Musisi S, et al.
    Cango Lyec (Healing the Elephant): Gender differences in HIV infection in post-conflict Northern Uganda.
    J Acquir Immune Defic Syndr 2018.

  30. Thomson KA, Hughes J, Baeten JM, John-Stewart G, et al.
    Increased Risk of Female HIV-1 Acquisition Throughout Pregnancy and Postpartum: A Prospective Per-coital Act Analysis Among Women with HIV-1 Infected Partners.
    J Infect Dis 2018.

  31. Stefic K, Novelli S, Mahjoub N, Seng R, et al.
    Non-reactive HIV-1 Rapid Tests after Sustained Viral Suppression Following Antiretroviral Therapy Initiation During Primary Infection.
    J Infect Dis 2018.

  32. Volz EM, Le Vu S, Ratmann O, Tostevin A, et al.
    Molecular Epidemiology of HIV-1 Subtype B Reveals Heterogeneous Transmission Risk: Implications for Intervention and Control.
    J Infect Dis 2018.

  33. Mofenson LM.
    Risk of HIV Acquisition during Pregnancy and Postpartum: A Call for Action.
    J Infect Dis 2018.

  34. Baeten JM.
    Amplifying the Population Health Benefits of PrEP for HIV Prevention.
    J Infect Dis 2018.

  35. Gao L, Wang Y, Li Y, Dong Y, et al.
    Genome-wide expression profiling analysis to identify key genes in the anti-HIV mechanism of CD4(+) and CD8(+) T cells.
    J Med Virol 2018.

  36. Hessell AJ, Shapiro MB, Powell R, Malherbe DC, et al.
    Reduced cell-associated DNA and improved viral control in macaques following passive transfer of a single anti-V2 monoclonal antibody and repeated SHIV challenges.
    J Virol 2018.

  37. Kristensen AB, Kent SJ, Parsons MS.
    Contribution of NK cell education to both direct and anti-HIV-1 antibody-dependent NK cell functions.
    J Virol 2018.

  38. Shi J, Xiong R, Zhou T, Su P, et al.
    HIV-1 Nef antagonizes SERINC5 restriction by downregulation of SERINC5 via the endosome/lysosome system.
    J Virol 2018.

  39. Panasiuk M, Rychlowski M, Derewonko N, Bienkowska-Szewczyk K, et al.
    Tunneling nanotubes (TNT) as a novel route of cell-to-cell spread of herpesviruses.
    J Virol 2018.

  40. Huan C, Li Z, Ning S, Wang H, et al.
    Long non-coding RNA uc002yug.2 activates HIV-1 latency through regulating mRNA level of various RUNX1 isoforms and increasing Tat expression.
    J Virol 2018.

  41. Carnathan DG, Mackel JJ, Sweat SL, Enemuo CA, et al.
    Intragastric administration of Lactobacillus plantarum and AT-2-inactivated SIV does not protect Indian rhesus macaques from intra-rectal SIV challenge nor reduce virus replication after transmission.
    J Virol 2018.

  42. Ashokkumar M, Aralaguppe SG, Tripathy SP, Hanna LE, et al.
    Unique phenotypic characteristics of recently transmitted HIV-1 subtype C envelope glycoprotein gp120: Use of CXCR6 co-receptor by transmitted founder viruses.
    J Virol 2018.

  43. Gottlieb GS, Raugi DN, Smith RA.
    HIV Drug Resistance.
    N Engl J Med 2018;378:874-5.

  44. Bertagnolio S, Jordan MR, Doherty M.
    HIV Drug Resistance.
    N Engl J Med 2018;378:874.

  45. Inzaule SC, Rinke de Wit TF, Hamers RL.
    HIV Drug Resistance.
    N Engl J Med 2018;378:873-4.

  46. Iroh Tam PY, Wiens MO, Kabakyenga J, Kiwanuka J, et al.
    Pneumonia in HIV-Exposed and Infected Children and Association with Malnutrition.
    Pediatr Infect Dis J 2018.


Display articles in


Amedeo HIV Infection

Data Origin

You selected the following journals for your Amedeo HIV Infection newsletter:

AIDS, AIDS Res Hum Retroviruses, Ann Intern Med, BMJ, Clin Infect Dis, J Acquir Immune Defic Syndr, J Clin Immunol, J Clin Invest, J Infect Dis, J Med Virol, J Virol, JAMA, Lancet, N Engl J Med, Nat Med, Pediatr Infect Dis J, Science, Virology.

To modify the journal selection, please open your Newsletter Management Page. If you don't remember the URL, please submit the email address of your Amedeo subscription.

Your email:



Amedeo HIV Infection

Five-Week Literature

10 December 2018

03 December 2018

26 November 2018

19 November 2018

12 November 2018


12 March 2018

Multidisciplinary Journal Club

  1. Moore A, Derry S, Wiffen P.
    Gabapentin for Chronic Neuropathic Pain.
    JAMA. 2018;319:818-819.

  2. Snow RW, Sartorius B, Kyalo D, Maina J, et al.
    The prevalence of Plasmodium falciparum in sub-Saharan Africa since 1900.
    Nature. 2017 Oct 11. doi: 10.1038/nature24059.

  3. Wang Y, Kuang Z, Yu X, Ruhn KA, et al.
    The intestinal microbiota regulates body composition through NFIL3 and the circadian clock.
    Science. 2017;357:912-916.

Every week, Amedeo's Multidisciplinary Journal Club (MJC) presents a selection of outstanding articles. Take a look beyond the horizon.


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016